Bone phenotype of lysyl oxidase isoform knockout mice & in vitro expression of lysyl oxidase proenzyme (II) by Alsofi, Loai Abdulfattah M.
Boston University
OpenBU http://open.bu.edu
Goldman School of Dental Medicine GSDM: Historical Theses and Dissertations (Open Access)
2012
Bone phenotype of lysyl oxidase
isoform knockout mice & in vitro
expression of lysyl oxidase
proenzyme (II)
https://hdl.handle.net/2144/31296
Boston University
BOSTON UNIVERSITY 
GOLDMAN SCHOOL OF DENTAL MEDICINE 
DISSERTATION 
BONE PHENOTYPE OF LYSYL OXIDASE ISOFORM KNOCKOUT MICE 
& 
IN VITRO EXPRESSION OF L YSYL OXIDASE PRO ENZYME (II) 
LOAI A. ALSOFI 
B.D.S. King Abdul-Aziz University, 2001 
DSc, Boston University, 2008 
CAGS, Boston University, 2011 
Submitted in partial fulfillment of the 
requirements for the degree of 
Master of Science in Dentistry 
In the Department of 
Oral Biology 
2012 

READERS APPROVAL 
First Reader 
Date I 
Second Reader 
Date 
DEPARTMENTAL APPROVAL 
Department Chairperson 
Date ( 1 
Philip Trackman, Ph.D. 
Professor 
Director of Oral Biology Research 
Department of Periodontology and 
Oral Biology 
Louis C. Gerstenf eld, Ph.D. 
Professor, Department of 
Orthopedic Surgery 
Director of Musculoskeletal 
Research Laboratory 
Serge Dibart , DMD 
Professor and Chair 
Dept. of Periodontology and Oral 
Biology 
Director Advanced Specialty 
Progr · Periodontics 
Acknowledgments 
I would like to thank Dr. Philip Trackman for giving me the opportunity to work under 
his guidance. He has been an excellent mentor and advisor and I am honored that I have 
worked with him. 
I would like to thank my friends in the lab, who shared their information with me. 
Also, I would like to thank Dr. Louis Gerstenfeld and Dr. Elise Morgan and for helping 
us with our project. 
I would like to express special thanks to my parents and brothers for their 
encouragement and prayers. 
Mostly, I would like to thank my wife Hanaa and my sons Omar and Redwan 
for being with me through these years. They shared with me all the good and bad 
moments. 
111 
BONE PHENOTYPE OF LYSYL OXIDASE ISOFORM KNOCKOUT MICE 
& 
IN VITRO EXPRESSION OF L YSYL OXIDASE PRO ENZYME 
LOAI A. ALSOFI 
Boston University, Goldman School of Dental Medicine, 
2012 
Major Professor: Philip Trackman, Ph.D, 
Professor of Periodontology and Oral Biology 
ABSTRACT 
Lysyl oxidases constitute a family of enzymes responsible for the formation of cross-
links in collagen and elastin. These enzymes have also been linked to pathological fibrosis. 
The importance of collagen in the structural and mechanical properties of bone led us to 
investigate the hypothesis that the absence of one or more of these enzymes could lead to a 
significant bone phenotype. This phenotype could resemble osteoporosis or diabetic bone 
disease. In addition, we tried to overexpress lysyl oxidase proenzyme in vitro. The ability to 
produce enough amounts of lysyl oxidase proenzyme and the ability to process it and activate 
it could facilitate the development of drugs that control its activity in pathological fibrosis. 
IV 
Bones from 12-week old mice (8 males and 8 females) with the genotype LOX+/-, 
LOXLI -/- were analysed. 8 males and 8 females of the genotype LOXLl-/- were also 
analysed. 16 wild type mice (8 males and 8 females) were used as controls. µCT was used to 
analyse the trabecular and cortical bone morphology of both left femur and L5 vertebrae 
(n=8). Right femurs (n=5) were used for histology and histromorphometric analysis. Tibia 
and fibula (n=5) were used for cross-link analysis. One-way anova with Tukey HSD post-hoc 
test was used to assess the influence of genotype on skeletal morphology. AP value with less 
than 0.05 was considered statistically significant. µCT analysis of the trabecular bone in 
femur distal metaphysis and L5 vertebrae of LOX+/-, LOXLI-/- and LOXLl-/- mice showed 
significantly decreased relative bone volume, connectivity density and trabecular number and 
significantly increased trabecular spacing. Cortical bone in femur mid-diaphysis region of 
LOX+/-, LOXLl-/- and LOXLI-/- mice showed significantly increased cortical thickness 
and polar moment of inertia. Crosslink analysis showed that the total number of LOX-
catalyzed aldehydes was significantly lower in LOX+/-, LOXLI-/- mice. Histological 
analysis showed that osteoclast ratio is significantly increased on trabecular bones surface in 
femur metaphysis in LOX+/-, LOXLI-/- male and female mice and LOXLl-/- female mice. 
Analysis of the growth plates showed that there is a significant decrease in the average 
number of flat column-forming cells in LOX+/-, LOXLl-/- male and female mice and 
LOXLl-/- female mice. 
For expression of lysyl oxidase proenzyme, we used a tetracycline-regulated 
expression with and monkey COS-7 fibroblasts to express and release the rat lysyl oxidase 
proenzyme. The expression system consists of a regulatory vector (pcDNA6/TR) and an 
V 
expression vector that contained the rat lysyl oxidase proenzyme sequence preceded by 
osteonectin signal peptide. Cells containing the regulatory vector were transiently transfected 
with the expression vector and induced with tetracycline for 24 hour after transfection. Media 
were analyzed for lysyl oxidase expression using Western blots. COS-7 cells expressed and 
secreted a reasonable amount of lysyl oxidase proenzyme into the culture media 48 hours 
after induction. Medium was collected and lysyl oxidase proenzyme was purified and 
processed by BMP-1. Processing was confirmed by W estem blots and a fluorometric assay 
was used to analyze the lysyl oxidase enzyme activity. 293 EBNA cells were also used to 
express and lysyl oxidase proenzyme. The secreted proenzayme was preceded by Histidine 
tag and was purified using nickel column. We were unable to process the proenzyme using 
BMP-1. 
LOX+/-, LOXLl-/- and LOXLl-/- mice develop a significant bone phenotype 
characterized by porosity and increased spacing between the trabeculae. This could 
predispose bones to micro fracture and to be easily resorbed during bone turnover. Bone in 
these mice may have similarities to osteopenic bones in pathologies such as diabetes or 
osteoporosis. Lysyl oxidase proenzyme can be expressed and then collected and purified. 
Processing of lysyl oxidase proenzyme produces the active 32-kDa mature enzyme. 
Development of drugs that can control this activity will be useful in treating fibrotic disease 
where lysyl oxidase is upregulated. 
Vl 
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1. Introduction 
1.1. Preview 
The posttranslational modifications of proteins are important for determining the 
higher-ordered level of protein structure. Certain amino acid residues within the peptide 
chain are subjected to specific enzymatic modifications that affect the three-dimensional 
structure and stability of these polymers. Two factors determine the specificity of these 
reactions, which are a certain recognition sequence in the target protein and the 
compartmentalization of the enzymes (Lucero and Kagan 2006). 
Collagen is a triple helical protein and constitutes a major part of the extracellular 
matrix in different tissues. It is the main structural protein in the body making up to 25% 
of the whole body protein content and provides tissues with strength and support. More 
than 90% of the collagen in the body is type II, III, IV, and I with type I as the major type 
of collagen in bone. Type I collagen is the most abundant collagen in the human body. It 
is also found in tendons, skin, artery walls, and teeth. Type II collagen is found primarily 
in hyaline cartilage. Reticular fibers are composed mainly of type III collagen. Type IV 
collagen is the main component of basement membranes. 
Collagen is synthesized via complex pathways involving intracellular and 
extracellular post-translational modifications. It is made of 3 a polypeptide chains that are 
wound to one other in a rope-like super helix. Collagens are extremely rich in proline and 
glycine. Glycine is present at every 3rd amino acid residue throughout the central region 
of the a chain. The a chains are synthesized as large precursors called pro-a-chains which 
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posses propeptide regions both at their N- anc C-termini. Each chian is about I 000 amino 
acid long and is arranged as a left-handed helix, with three amino acids per tum, and 
glycine comes as every third amino acid. Therefore, an a-chain is composed of a series of 
triplet Gly-X-Y sequences. X and Y can be any amino acid, with most commonly Y as 
proline or hydroxyproline. 
Within the endoplasmic reticulum, procollagen chains undergo proline and lysine 
hydroxylation by prolyl hydroxylase and lysyl hydroxylase enzymes, respectively 
(Walker, Overstreet et al. 2005). After proline and lysine modifications, each pro a-chain 
then combines with two others to form a hydrogen-bonded triple-stranded helical 
molecule known as procollagen triple helical collagen is then secreted into the 
extracellular environment. Once there, additional posttranslational modifications take 
place that lead to the maturation and cross-linking required for normal extracellular 
matrix development and maturation. 
The N- and C-terminals of the secreted procollagen are removed in the 
extracellular environment by procollagen N-proteinase and C-proteinase, respectively 
(Prockop, Sieron et al. 1998). The resulting tropcollagen is less soluble and prone to 
higher order organization (Mould, Hulmes et al. 1990). The C- terminal proteinases are 
members of the astacin family of enzymes and are products of the Bmp 1, Till and Tl/2 
genes. In addition to the removal of C-terminal region from procollagen, procollagen C-
protinases also process prolysyl oxidase into its mature form (Cronshaw, Fothergill-
Gilmore et al. 1995). Removal of the N-terminal propeptide from the secreted 
2 
procollagen molecules is accomplished by members of the ADAMTS family of enzymes 
(metalloproteinase with thrombospondin type I repeat) (Colige, Vandenberghe et al. 
2002). 
1.2. Properties of Lysyl Oxidase 
Lysyl oxidase has been recognized as the catalyst for the posttranslational 
oxidation of the €-amino group of specific peptidyl lysine and hydroxylysine residues of 
collagen and of lysine in elastin. The oxidative deamination of the €-epsilon amino 
groups of lysine and hydroxy lysine residues results in the formation of peptidyl aldehyde 
products (a-aminoadipic-cr-semialdehyde) in collagen. (Kagan and Track.man 1991). 
These aldehydes react spontaneously with unmodified lysine residues or with other 
peptidyl aldehyde residues to form a variety of intra- and intermolecular cross links that 
result in the formation of mature functional extracellular matrix, which is necessary for 
subsequent mineralization (Knott and Bailey 1998). The importance of lysyl oxidase is 
revealed by studies in animal models. LOX-gene targeted mice (LOX-I-) die immediately 
after birth. Tissue analysis showed cardiovascular instability, ruptured arterial aneurysms, 
and diaphragmatic ruptures. Histological analysis shows that the elastic fibers in the aorta 
are fragmented (Homstra, Birge et al. 2003). A study by Pischon et al suggest that the 
inhibition of lysyl oxidase expression in osteoblasts by TNF-a without inhibiting collagen 
synthesis results in the formation of perturbed collagen cross-linking and abnormal 
accumulation of collagen (Pischon, Darbois et al. 2004). The previous studies provide 
evidence that lysyl oxidase is crucial for survival and is important for mature collagen 
deposition and maturation. 
3 
Lysyl oxidase is initially synthesized as a 46-kDa proenzyme, which contains the 
N-terminal signal peptide. After signal peptide removal and N-glycosylation, this protein 
is secreted from the cell as an N-glycosylated inactive 50-kDa proenzyme (Trackman, 
Bedell-Hogan et al. 1992). Proteolytic cleavage of the rat lysyl oxidase proenzyme 
between gly 162 and Asp 163 results in the formation of the functional 32-kDa mature 
lysyl oxidase enzyme and the 18-kDa propeptide (Cronshaw, Fothergill-Gilmore et al. 
1995). 
Lysyl oxidase activity is inhibited by the administration of a specific agent called 
~-aminopropionitrile (BAPN), an enzyme-activated irreversible inhibitor (suicide 
substrate) and is the most often used inhibitor, or by copper depletion (Kagan 1994). 
Lathyrism, a condition resulting from lysyl oxidase inhibition, is characterized by a 
variety of connective tissue abnormalities such as aortic ruptures, skeletal deformities and 
fragility. Analysis of lathyritic tissues showed that collagen is abnormally soluble and 
elastic fibers are defective. Lysine-derived cross-links are decreased and lysine content is 
increased. 
The mature enzyme can re-enter the cell and can localize to the nucleus. Studies 
have shown its effects on gene transcription. An in vitro study by Nellaiappan et al shows 
that lysyl oxidase, once secreted and proteolytically cleaved, can enter and concentrate 
within the nuclei of aortic smooth muscle cells. The study shows that the presence of 
BAPN did not significantly affect the entry of LOX into the nucleus (Nellaiappan, 
Risitano et al. 2000). 
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Recombinant lysyl oxidase was frrst expressed in Chinese hamster ovary cells 
from cDNA encoding either the full length LOX or the truncated form missing the 
propeptide region. LOD-06 cell line was generated by transfection with the full-length 
Lox cDNA and yielded lysyl oxidase proenzyme (50 k:Da) and lysyl oxidase mature 
enzyme (29 k:Da). LOD32-2 cell line was generated by transfection with truncated cDNA 
sequence and yielded identical mature lysyl oxidase enzyme (29 k:Da) to that produced by 
LOD-06 cell line. Both mature products had the same specificity and were inhibited by 
the same chemical inhibitors. These results indicate that the N-terminal part of the 
propeptide region is not essential for the proper folding, catalytic function and secretion 
of mature lysyl oxidase (Kagan, Reddy et al. 1995). The necessity of the propeptide 
region for lysyl oxidase secretion was later proven by other study. Sommer et al, shows 
that the complete removal of the propeptide region from recombinant lysyl oxidase 
proenzyme prevented its secretion from myofibroblast-like cells (Thomassin, Wemeck et 
al. 2005). 
1-10 mg of the 32-k:Da mature enzyme has been purified from 300 to 1000 g of 
bovine aorta. The insolubility of this protein makes the extraction possible only by 
buffered 4-6M urea. The lack of solubility led to the precipitation of the catalyst in the 
absence of urea (Kagan and Sullivan 1982). 
1.3 Family Members of Lysyl Oxidase 
Four enzymes have been identified that posses the same catalytic activity as lysyl 
oxidase and are called LOX-like proteins (LOXLl, LOXL2, LOXL3, and LOXL4). 
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These proteins have significant sequence similarity with the mature lysyl oxidase but 
differ in the propeptide region (Csiszar 2001). LOX and LOXLl are secreted into the 
extracellular environment as pro-proteins. Proteolytic cleavage of the pro-proteins 
releases the C- terminal catalytic domain and the N-terminal propeptide (Csiszar 2001). 
Both proteins are processed by procollagen C-proteinase (PCP) or less efficiently by 
mammalian tolloid proteinases (Uzel, Scott et al. 2001). The removal of the N- and C-
pro-peptides from febrile procollagen by N- and C- proteinases is necessary for the 
assembly of individual collagen molecules into quarter staggered fibrillar aggregates 
(Mould, Hulmes et al. 1990). In conclusion, we can say that the action of PCP on 
procollagen is considered a regulatory step in the maturation of collagen. This regulation 
is achieved by the formation of fibrillar collagen and by processing LOX and LOXL 1 
into mature enzymes to catalyze cross-linking. 
Analysis of the expression patterns of lysyl oxidases revealed wide and variable 
distribution in different tissues of the body. In vitro studies on osteoblastic cells (MC3T3-
E 1) shows that lysyl oxidase is regulated as function of osteoblast phenotype 
development. The study shows that maximum increase in lysyl oxidase activity occurs 
before the accumulation of insoluble collagen (Hong, Pischon et al. 2004). Little is 
known about substrate specificity of lysyl oxidases. LOXLl is known to act on elastin 
rich substrates (Borel, Eichenberger et al. 2001) and LOXL4 oxidized collagen rich 
substrate and does not need processing (Ito, Akiyama et al. 2001 ). 
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Animal studies have shown that lysyl oxidase null mice die after birth and 
experience cardiovascular instability with ruptured arterial aneurysms and diaphragmatic 
rupture (Homstra, Birge et al. 2003). LOXLI null mice are viable but they experience 
defects in elastic fiber deposition. They lack normal deposition of elastic fibers in the 
uterine tract. They also have enlarged airspaces of the lungs, loose skin, and vascular 
abnormalities (Liu, Zhao et al. 2004). 
1.4 Collagen Cross-Links 
The maturation of collagen molecules by cross-link formation is important to 
stabilize the fibrous forms of the molecule and render it insoluble. Collagen is considered 
the major fiber in the extracellular matrix. It forms 90% of the organic matrix of bone. 
Along with mineral content, it determines the biomechanical properties and functional 
integrity of this hard tissue. Improper cross-link formation results in pathological and 
dysfunctional tissues. 
An initial step before extracellular cross-link formation is intracellular lysine 
hydroxylation by the enzyme lysyl hydroxylase. Hydroxylation of specific lysine residues 
determines future cross-link formation and plays a role in the biomechanical properties of 
tissues. Deficiency of lysyl hydroxylase enzyme activity results in Ehler Danlos 
Syndrome. The condition is characterized by connective tissue dysfunctions such as 
osteoporosis and rupture of the eye and aorta. In bone, type IV collagen hydroxylation is 
reduced to 17% of normal bone (Otsubo, Katz et al. 1992). Hydroxylysine residues 
undergo glycosylation prior to triple helix formation. The function of this modification is 
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unknown (Knott and Bailey 1998). 
Collagen cross-links can be divided into mature and immature. Immature lysyl 
oxidase derived cross-links are of two types. The first is hydroxylysine aldehyde derived 
cross-links (ketoimines ). This type of cross-link is formed from the condensation of 
telopeptide aldehyde with the triple helical hydroxy lysine to form Schiff' s base. An 
example of this cross-link is hydroxylysine-5-ketonorleucine (HLKNL). This cross-link 
can be stabilized by chemical reduction with NaB~ to its reduced form dihydroxy-
lysinonorleucine (DHLNL). The second type is lysine aldehyde derived cross-link 
(aldimines). An example of this type is dehydro-hydroxy-lysinonorleucine (deH-HLNL), 
which is formed from the condensation of the telopeptide lysine aldehydes with helical 
hydroxylysine residues. The NaBH4-reduced form of this cross-link 1s 
hydroxylysinonorleucine (HLNL). Another example is dehydrolysinonorleucine (deH-
LNL ), which is formed form the condensation of the telopeptide lysine aldehydes with 
helical lysine residues. 
Mature enzymatic cross-links in collagen are trivalent and more stable than the 
immature cross-links. There are three types of trivalent cross-links. One of them is 
hydroxylysyl pyridinoline (HL-Pyr), which is composed of two hydroxylysyl-aldehyde 
resides and a helical hydroxylysine. Another trivalent cross-link is lysyl-pyridinoline (L-
Pyr) which is formed from two hydroxylysine aldehydes and a lysine residue. The pyrrole 
cross-link is proposed as a trifunctional maturation of the ketoimines (Knott and Bailey 
1998). 
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1.5 Collagen Modification with Age 
Aging results in the reduction in the amount of enzymatic cross-links, which get 
replaced by nonenzymatic transformations. The early transformations are reversible and 
do not tend to accumulate. More persistent transformations occur in collagen with aging 
such as advanced glycation end products (AGEs or Maillard products). These 
modifications cause increased tissue stiffness in the skin, tendons, and basement 
membrane. Due to high turnover in bone, these modifications do not accumulate as much 
(Knott and Bailey 1998). Pentosidine is nonenzymatic cross-link and is of little 
biochemical importance compared to enzymatic cross-links (Sell and Monnier 1989). 
Another modification found in type I collagen is the Asp-Gly ~-isomerization within the 
C-telopeptide (Knott and Bailey 1998). 
1.6 Bone Biology 
Three different cell types are responsible for the production, maintenance, and 
remodeling of bone tissue. Osteoblasts arise from mesenchymal stem cells under the 
appropriate influencing conditions. They are responsible for the production of bone 
matrix, which is mainly type I collagen and are responsible for mineralization of the 
matrix. Osteoclasts originate from hematopoietic stem cells and are responsible for bone 
resorption by removing its mineralized matrix. Osteocytes are previous osteoblasts, 
which got entrapped in lacunae. 
Bone mass is regulated throughout life by a delicate balance between resorption 
and formation. During growth, an increase in bone formation over resorption results in a 
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total increase in bone mass (Cao, Wronski et al. 2005). Reaching adulthood, a balance is 
maintained with continuous remodeling. This balance is disturbed with aging and with 
certain pathological conditions resulting in either abnormal bone growth or enhanced 
bone loss. Bone remodeling is regulated by OPG/RANKL/RANK system. OPG 
( osteoprotegrin) is secreted by osteoblastic cells and acts as a soluble decoy receptor that 
binds RANKL and prevents RANKL binding to its receptor RANK on osteoclast cells. 
RANKL is an important osteoclast differentiation factor. The binding of OPG to RANKL 
prevents preosteoclast differentiation into osteoclasts (Khosla 2001; Sims and Gooi 
2008). 
OPG mRNA was found in different tissues including lung, heart kidney, liver, 
stomach, and bone (Simonet, Lacey et al. 1997). The importance of OPG for bone is 
revealed in animal studies. Mice with OPG ablation not only develop severe osteoporosis, 
but also have profound calcification of the large arteries, marked intimal and medial 
proliferation, and partial aortic dissection at 4 months of age (Bucay, Sarosi et al. 1998). 
The OPG/RANKL/RANK system provides a mechanism by which 
preosteoblastic cells control osteoclast development. Indeed, preosteoblastic cells control 
bone remodeling by producing OPG and expressing RANKL on their surface. The 
process starts by migration of osteoclasts to the appropriate site and resorbing the bone. A 
reversal phase then takes place by apoptosis of osteoclasts. Bone formation follows by 
newly formed osteoblasts. This coupling insures that bone resorption is immediately 
followed by new bone formation (Khosla 2001). Further coupling between bone 
10 
formation and bone resorption is insured by the fact that osteoblast differentiation factor 
(cbfal) is necessary for the expression of RANKL on the surface of 
preosteoblastic/stromal cells (Gao, Shinlci et al. 1998). 
RANKL, which is expressed on the surface of preosteoblastic/stromal cells is 
necessary for the development of osteoclasts. It is crucial for the differentiation, fusion 
into multinucleated giant cells, activation, and survival of osteoclasts. OPG blocks this 
system by binding to RANK and preventing its effects. Another important factor for 
osteoclast development is M-CSF (macrophage-colony stimulating factor). It is also 
considered the primary factor in pooling of the precursor cells. It is also secreted by 
preosteoblastic/stromal cells and binds to c-Fms receptor on the surface of preosteoclastic 
cells (Gao, Shinlci et al. 1998). 
In addition to the OPG/RANKL/RANK system and M-CSF, several cytokines 
were found to have effects on the regulation of bone remodeling. Those include IL-1, IL-
4, IL-6, IL-11, prostaglandin (PGE2), estradiol, TNF-a, and tranforming growth factor-~. 
These cytokines are produced by bone marrow stromal cells and osteoblasts and 
modulate osteoclast differentiation and activity (Jilka 1998). A study by Hofbauer et al in 
1999 shows that the pro-inflamatory and bone-resorbing cytokines IL-1 ~ and TNF-a, but 
not IL-6, upregulated RANKL mRNA levels in different human osteoblastic cells. The 
stimulation was time and dose dependent (Hofbauer, Lacey et al. 1999). Takai et al 1998, 
shows that TGF-~ induces the expression of OPG in bone marrow stromal cells. The 
stimulation was both in the transcriptional and posttranscriptional mechanism. 
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Parathyroid hormone was found to increase RANK production and decrease OPG 
production, an effect that enhances bone resorption. Experiments on mouse bone marrow 
culture by Lee and Lorenzo 1998, showed that PTH increased the number of osteoclasts, 
enhanced TRANCE mRNA levels, and inhibited the expression of OPG mRNA. 
TRANCE stands for tumor necrosis factor-related activation-induced cytokine. It is a 
stimulator of osteoclast formation and important for osteoblast-mediated osteoclast 
differentiation and activation (Lee and Lorenzo 1999). 1,25-dihydroxyvitamin D3 and 
glucocorticoids increase RANKL production (Hofbauer, Gori et al. 1999; Kitazawa, 
Kitazawa et al. 1999). Estrogen increased OPG production (Hofbauer, Gori et al. 1999), 
while glucocorticoids decrease OPG production (Hofbauer, Gori et al. 1999). 
Normal bone remodeling is regulated via different factors and cytokines. It is a 
complicated process, hence well controlled to maintain optimum bone mass and integrity. 
Bone mass and density can be adversely affected by imbalances between formation and 
resorption. Hormonal, mechanical and physiological factors could affect these conditions 
leading to either increased or decreased bone mass and density. 
1. 7 Osteoporosis 
Osteoporosis is characterized by loss of bone mass and strength, which renders 
the bone fragile and prone to fractures. The condition is common in postmenopausal 
women due to estrogen deficiency and the loss of its stimulatory effect on OPG 
production. Thus there is more bone resorption, due to the unopposed effect of RANKL 
on osteoclast differentiation and activation, which exceeds bone formation (Bouxsein, 
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Myers et al. 2005). Other factors in the pathophysiology are the prolonged lifespan of 
osteoclasts and the early apoptosis of osteoblasts and osteocytes. A study by Liu et al 
2005, suggests a novel pathophysiological mechanism for the development of 
osteoporosis. The suggested mechanism is characterized by increased recruitment of 
circulating monocytes into bone followed by increased differentiation into osteoclasts. 
Real time PCR confirmed that three genes are up regulated and are correlated with 
decreased bone mineral density. Those genes are CCR3 (chemokine receptor 3), HDC 
(histidine decarboxylase ), and GCR (glucocorticoid receptor) (Liu, Dvomyk et al. 2005). 
Inflammation plays an important role in the development of osteoporosis. The 
increased levels of TNF-a during inflammation have detrimental effects on bone. TNF-a 
activates the transcription factor nuclear factor kappa B (NF-KB) and stimulates 
apoptosis. TNF-a is considered a bone catabolic factor by stimulating osteoclastogenesis 
and inhibiting osteoblast formation or inhibiting their bone-forming action. TNF-a also 
plays an important role during osteoclastogensis by upregulating the osteoclastic genes. 
Different studies proved that TNF-a has a central role in the pathophysiology of 
postmenopausal osteoporosis (Pacifici 1996; Horowitz, Xi et al. 2001 ). Reports show that 
treatment of cell cultures of mineralizing osteoblasts with TNF-a resulted in increased 
calcium release and suppression of matrix protein production (Bertolini, Nedwin et al. 
1986; Canalis 1987). 
Bone loss during osteoporosis affects both cortical and trabecular bone. Cortical 
bone loss affects the cortical shell in the vertebrae, pelvic, and forearm bones. Cortical 
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bone loss is less drastic than trabecular bone loss. Loss of trabecular bone affects bone 
architecture, reduces the mechanical properties of the total bone organ, increases fracture 
susceptibility, and impairs healing (Thomassin, Wemeck et al. 2005). Studies on different 
strains of mice show that they lose cortical and trabecular bone, though with site 
variability, one month after ovarectomy (Bouxsein, Myers et al. 2005). 
Bone mineral density is considered an important factor of bone quality. Optimum 
BMD is achieved during early childhood and is a major determinant of the risk of 
osteoporosis (Melton, Kan et al. 1989). It is affected during aging at different sites in both 
men and women. The decrease is observed to be greater in women then men and began 
even before middle life (Khosla and Riggs 2005). The combined loss of cortical and 
trabecular bone and the decrease in bone mineral density determines to great extent the 
risk of fracture. The frequency of bone fractures increases with loss of bone mass due to 
aging, genetic or environmental factors (Smith, Nance et al. 1973). 
1.8 Diabetic Bone Disease 
Loss of bone tissue is common in diabetic patients. Clinical evidence suggests 
that it is associated with diminished bone formation with or without enhanced bone 
resorption. The pathophysiology of diabetic bone loss involves mechanical, hormonal, 
and vascular factors (Reddy, Stehno-Bittel et al. 2001). A study by Saito et al (2006) 
indicates that after the onset of type II diabetes in rats, there is a steady decrease in 
enzymatic cross-links and a steep increase in pentosidine. Femurs from seventy diabetic 
male WBN/Kob rats, 1-18 months old were subjected to bone mineral density analysis, 
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cross-link analysis and three-point bending test. Seventy normal male Wistar rats were 
used as the non-diabetic, age-matched control. The diabetic rats suffered from impaired 
bone mechanical properties and normal bone mineral density. The results indicate that 
the alteration in enzymatic and non-enzymatic cross-linking could contribute to fracture 
susceptibility in diabetes (Saito, Fujii et al. 2006). 
1.9 Determinants of Bone Strength 
Bone strength is governed by its mass, shape and geometry, microarchitecture, 
and material properties of the matrix (Gamero and Delmas 2004; Viguet-Carrin, Gamero 
et al. 2006). These factors are determined by the quality of the organic part of the 
extracellular matrix and the inorganic mineral content. Bone mineral density is 
considered a factor in determining bone quality, but is not an accurate predictor of bone 
strength (Viguet-Carrin, Gamero et al. 2006). Looking at the other part of the matrix, 
which is mainly collagen, it was found that collagen properties are important determinant 
of bone strength. Abnormalities in collagen deposition and maturation can affect the 
mechanical properties of bone and increase fracture susceptibility. Several studies 
suggest that discrepancies in bone strength are in some part due to decreased mineral 
density and in some part due to defects in the quality of collagenous matrix, including the 
nature and extent of posttranslational modifications. A study by Gamero et al (2006) 
concluded that the extent and nature of collagen cross-linking is a major determinant of 
the mechanical properties of cortical bone independent of bone mineral density. The 
study is based on incubating bovine cortical bone specimens at 37° C for 0, 60, 90 and 
120 days in order to modify the extent of collagen type I cross linking with maintaining 
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constant architecture and mineral content. After 60 days of incubation, there was an 
increase in the amount of enzymatic cross-links (PYO and DPD) and non-enzymatic 
cross-links (pentosidine and C-telopeptide isomerization). These changes were associated 
with decrease in bending and compressive yield stress and increase in compressive post-
yield energy absorption. Bone stiffness, which is proposed to be associated with mineral 
content, did not change (Gamero, Borel et al. 2006). Improper collagen cross-linking 
jeopardizes bone quality and plays an important role in the etiology of osteoporotic 
fractures (Hernandez, Tang et al. 2005). 
Osteoporotic fractures that affect trabecular bone can lead to permanent damages 
within the bone, as these trabeculae may not be replaced during bone turnover (Parfitt 
1984; Fyhrie and Schafller 1994). SAMP stands for the senescence-accelerated prone 
mouse. This is a mouse strain that exhibits certain pathologies. SAMP6 emerged as a 
senile model for osteoporosis. Analysis of the femoral bones from SAMP6 osteoporotic 
mice show that their bones are weak and brittle compared to their controls SAMR I mice. 
SAMP6 mice experience many features of the osteoporotic disease like decreased 
trabecular bone formation. Femora were collected from 4 and 12 month-old SAMP6 mice 
and compared to SAMRl mice. Quantitative histology, collagen cross-link biochemistry 
and torsional mechanical testing were done. The results show that the weakness of the 
bones is attributed to a defect in the strength of bone matrix. It is mainly due to poorer 
organization of collagen fibers and reduced collagen content (Silva, Brodt et al. 2002). 
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1.10 Growth Plates of Bone 
Several studies showed that abnormalities in bone could be attributed to defects in 
the growth plates. The precise regulation of chondrocyte proliferation and hypertrophy 
govern the growth of the skeletal element. Correct morphogenesis depends on the 
integration of proliferation and hypertrophy of proliferative chondrocytes over the entire 
width of the growth plate (Hunziker 1988). A complex signaling network using different 
factors and proteins regulate the process of chondrocyte proliferation and differentiation. 
PTHrP is a paracrine hormone secreted from cells within the periarticular zone and acts 
to inhibit both the transition from proliferating to hypertrophic chondrocyte and the 
expression of Ihh. Cells located at a certain distance from PTHrP start to differentiate and 
secret Ihh. Ihh then positively feeds back on the cells within the periarticular zone by 
stimulating PTHrP expression and directly regulates chondrocyte proliferation and 
differentiation (Karp, Schipani et al. 2000; Kobayashi, Chung et al. 2002). 
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2. Correlation 
The direct effect of lysyl oxidase genes ablation on bone quality has yet to be 
established. This family of enzymes is important for normal collagen deposition and 
maturation, which in turn insure normal matrix quality and stability. Any abnormalities in 
the development of collagenous matrix may lead to bone loss and impaired bone quality. 
Bone quality is determined by the structural and material properties of the matrix, which 
have been proposed as major determinant of increased fracture risk in osteoporosis. 
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3. Hypothesis 
We wanted to investigate weather lysyl oxidases gene ablation could lead to poor 
bone quality as a result of improper collagen maturation. We therefore, analyzed bones 
from 12-week-old LOX+/- and LOXLJ-1- mutant mice. The analysis was done by µCT to 
evaluate bone architecture of these mice. To support µCT analysis, we did histological 
analysis of the bone and growth plates to investigate any abnormalities in normal 
biological mechanisms. Our hypothesis is that the absence of lysyl oxidases could lead to 
abnormal bone phenotype. 
As intent to produce and purify lysyl oxidase enzyme, we induced different kinds 
of cells to express and secret lysyl oxidase proenzyme. Attempts were then made to 
process it by BMP-1 gene products. Our hypothesis is that the ability to produce pure and 
active lysyl oxidase mature enzyme will enable us to modify or inhibit the activity of the 
enzyme. This may help in treating conditions caused by abnormal lysyl oxidase enzyme 
activity. 
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4. Materials and Methods 
4.1 Mouse Model 
LOX+/- and LOXLJ-1- mutant mice were kindly provided by Dr. Stephen Shapiro 
and Jingsong Xu, Harvard Medical School. LOXLJ-1- mouse tissues were provided by 
Dr. Ruth Ann word ofhe University of Texas Southwestern Medical Center. The LOX+/-
and LOXLJ-1- were in mixed background of strains 129/SvJ and C57BL/6. The wild type 
control mice were an Fl cross of 129/SVlMJ with strain C57BL/6 (B6129sF1, Jackson 
Laboratories). All tissues were harvested under the same specified conditions at 12 weeks 
of age. Each mutant strain was compared to wild type strain. Mutant mice were similar in 
size to wild type controls, as observed by similar femur lengths measured after sacrifice 
by caliper (Table I). Similarities were also seen in body weight and published 
characteristics (Liu, Zhao et al. 2004; Liu, Daneshgari et al. 2007). Mice were sacrificed 
by carbon dioxide asphyxiation. The left femurs and the spines were dissected and 
wrapped with saline-soaked gauze and stored in -20° C. They were then subjected to 
micro-computed topography (µCT) analysis. The right femurs were fixed with 4% 
paraformaldehyde and then processed for histological analysis using TRAP stain. Right 
and left tibia and fibula were stored at -20 ° C and then analyzed for lysyl oxidase-
dependent cross-links. 
4.2 Micro-Computed Tomography and Image Analysis 
Femurs and vertebrae (LS) were subjected to µCT at the Orthopedic and 
Developmental Biomechanics Lab, Boston University, Boston, MA using a Scanco 
Medical (Basserdorf, Switzerland) µCT 40 instrument. The power for the scans was 70 
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kVp, the current was 114 µA, and the integration was 200 msec. The femora were 
scanned at 12-microns/voxel resolution and the vertebrae were scanned at a resolution of 
16 microns/voxel. The regions selected for analysis were the trabecular areas of the distal 
metaphysis of the femurs and vertebrae (L5) and the cortical shell in the mid-diaphysis of 
femurs and vertebrae (L5). For distal femur metaphysis, the area of interest was 600-
micron thick in the trabecular section located 120 microns proximal to the growth plates. 
For the mid-diaphysis, the area of interest was 1200 microns thick. For the vertebrae 
(LS), the cortical shell and trabecular analysis were performed on a-800-microns-thick 
region located 160 microns proximal to the growth plates. The cortical shell was 
excluded by manually tracing every transvers 2D tomogram from trabecular region for 
trabecular area analysis. 
For partial noise suppression, a Gaussian filtering (sigma= 0.8, support = 1) was 
used. In order to identify mineralized tissue, a global threshold was applied. The 
threshold of choice was the X-ray attenuation (gray value) that corresponded to 45% of 
the attenuation of the cortical bone in the wild type bones (Morgan, Mason et al. 2009). 
X-ray attenuation values were used to calculate mineral densities by converting them to 
mineral density values using a standard curve. The standard curve was generated from 
scans of hydroxyapatite standards of known mineral densities. 
4.3 Trabecular Bone Analysis 
The parameters used to characterize trabecular bone structure are listed. TV ( total 
volume inside the contour [ mm3]) represents the total volume of the selected and 
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contoured slices. BV (bone volume [ mm3]) represents the total volume of the areas above 
the threshold and that should be considered bone quantified inside the contour of the 
selected slices. BV /TV (relative bone volume) represents the fraction of the volume 
inside the contour that is considered bone relative to the total volume inside the contour. 
Conn. D. (connectivity density, normalized by TV [1/ mm3]) is the average 
number of connections between the trabeculae in an area of one cubic millimeter. SMI: 
(structural model index) was an index with values between O and 3, where O indicate 
parallel shape of the trabeculae and 3 indicate that the trabeculae have a shape of 
cylindrical rods. Tb.N (trabecular number [1/mm]) is the average number of trabeculae 
between two imaginary parallel lines that were one millimeter apart. 
Tb.Th (trabecular thickness [mm]) is the average thickness of the trabeculae. Tb.Sp 
( trabecular separation = marrow thickness [mm]) was the average spacing between the 
trabeculae of the average marrow spaces. 
4.4 Cortical bone analysis 
Parameters such as TV, BV, BV/TV, cortical thickness and pMOI were used to 
analyze the mid-diaphysis region of femurs and the cortical shell of L5 vertebrae. pMOI 
is an abbreviation for polar moment of inertia, which is a measure of an object's ability to 
resist torsion. It is required to calculate the twist of an object subjected to a torque. 
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4.5 Histology and Histomorphometric Analysis 
The left femur from each animal was fixed for 72 hours in cold 4% 
parafonnaldehyde. 14% EDTA (American Bioanalytical, Natick, MA) decalcification 
was done for 3 weeks, and then the bones were embedded longitudinally in paraffin with 
inter-condylar notch at the distal end facing upward. Specimens were sectioned at 7 
microns and prepared for staining. Central sections were chosen for analysis. The 
analysis in each sample was assessed using computer image analysis. The program used 
is Image Pro Plus software (Media, Cybernetics, and Silver Spring, MD) 
Relative bone volume was calculated in the metaphysis area from 3 sections per 
animal stained with hematoxylin and eosin. The area selected from each slide is 0.1 mm 
away from the growth plate. The area selected excluded the outer cortex and extended 2.3 
mm away from the growth plates. Bone volume was calculated then divided by total 
volume of the analyzed area. 
The number of osteoclasts was determined by counting the number of multi-
nucleated tartrate-resistant acid phosphates (TRAP) positive cells on the surface of bone 
trabeculae in femur distal metaphysis area in five animals per group (n=5). Five tissue 
sections were used for each animal, and 5 representative areas from each slide were used 
for counting osteoclasts. 
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4.6 Histological stains 
a) Hematoxylin and Eosin Stain 
Slides were deparafinized in xylene followed by gradual rehydration starting with 
100% then 95% then 80% ethanol and ending with water. Staining then started with 
Harris modified hematoxylin (Fisher Scientific, Pittsburgh, PA) for 5 minutes followed 
by washing in slow running water for 5 minutes. Slides were then placed in 2% acid 
alcohol for 3 seconds followed by rinsing in running water for 1 minute. After that, slides 
were placed in 1 % ammonium water for 30 seconds and then rinsed in slow running 
water for 30 seconds. Counter staining was done with 0.5% eosin (Fisher Scientific, 
Pittsburgh, PA) for 2 minutes. Staining was followed by gradual dehydration through 
80%, 95% and 100% ethanol. After that, sides were placed in 2 changes of xylene for 3 
minutes each followed by cover slip mounting with paramount (Fisher Scientific, 
Pittsburgh, PA). 
b) TRAP Stain 
Total osteoclasts / unit area was determined by counting the number of multi-
nucleated tartrate-resistant acid phosphates (TRAP) positive cells on the surface of bone 
trabeculae in femur distal metaphysis area. Slides were deparafinized as mentioned and 
rehydrated, then incubated in 0.2 M sodium acetate (Sigma-Aldrich, St. Louis, MO) 
buffer for 20 minutes. The buffer also contains 50 mM L (+) tartaric acid (Sigma-Aldrich, 
St. Louis, MO). After the elapse of the incubation time, two additional materials were 
added to the same buffer. Those were 0.5 mg/ml napthol AS-MX phosphate (Sigma-
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Aldrich, St. Louis, MO) and 1.1 mg/ml fast red TR salt (Sigma-Aldrich, St. Louis, MO). 
The sections were then incubated for 1-2 minutes at 37°C. After that, the slides were 
monitored every minute until osteoclasts are bright red. The slides were then rinsed in 
distilled water followed by counterstaining with hematoxylin for 2-3 seconds. After that, 
the slides were rinsed with water for 5 minutes, air-dried overnight and mounted with 
paramount (Southern Biotech, Birmingham, AB). 
4. 7 Growth plate analysis 
Three central sections stained with H&E were selected from each animal. Several 
overlapping images were taken across the length of the growth plate using Image Pro 
Plus software at a magnification of 20 X. Panoramic photo merge of the overlapping 
images was done by using Adobe Photo Element 6 software (Adobe Systems 
Incorporated, Newton, MA). The panoramic photo merge for each slide was then 
analyzed using Image Pro Plus software. For each photo merge, the total growth plate 
area was calculated by tracing the contour of the growth plate. The average height of the 
growth plate was calculated by measuring the height at 5 different areas of the plate. The 
cellular density was calculated by counting the number of cells in each panoramic photo 
merge and then dividing by the plate surface area. The average number of column 
forming cells was calculated by counting the number of cells per column in 5 separate 
columns. 
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4.8 Collagen Cross-link Analysis 
The ends of the right and left tibia were cut and the soft and bone marrow were 
removed. The remaining cortical bone was pulverized into fine powder under liquid N2. A 
portion of pulverized bone was demineralized using 0.5 M of EDTA (Fisher Scientific), 
0.05 M of Tris-HCl, pH 7.4 for 10 days. EDTS solution was changed several times. The 
pulverized portions were then washed with distilled water and lyophilized. Two mg of 
demoralized collagen was reduced with standardized NaB3!4. The samples were 
subjected to constant boiling to be hydrolyzed and then subjected to amino acid and 
cross- link analysis. 
4.9 Statistical Analysis 
One-way anova with Tukey HSD post-hoc test was used to assess the influence of 
genotype on skeletal morphology. A P value with less than 0.05 was considered 
statistically significant. 
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4.10 Expression of the Rat Lysyl Oxidase Proenzyme Using COS-7 cells 
We used the TREX system (Figure 1) (In vitro gen, Carlsbad, CA) to express the 
rat lysyl oxidase proenzyme in COS-7 cells. The system consists of a regulatory vector 
and an expression vector. The regulatory vector ( 6. 7 kb) is pcDNA6/TR (Invitrogen, 
Carlsbad, CA). It expresses high levels of the tetracycline (tet) repressor, which regulates 
the expression vector. The expression vector (5.1kb) is pcDNA4/TO/myc-His (Invitrogen, 
Carlsbad, CA). The cDNA sequence of the rat lysyl oxidase proenzyme was inserted in 
the expression vector proceeded by osteonectin signal peptide. COS-7 cells (A TCC, 
Manassas, VA) were grown in DMEM media containing 10% FBS, 4 mM L-glutamine. 
When the cells were 90-95% confluent, they were transfected with the regulatory vector 
(2.4µg/ml) lipofectamine 2000 (Sigma-Aldrich, St. Louis, CA). The ratio of DNA to 
lipofectamine 2000 is 2:3 (W: V). Stable cells were selected using blasticidin (5µg/ml). 
Stable cells were grown in the same media with the addition ofblasticidin (5µg/ml). 
27 
pcDNA6/TR@ 
6.7 kb 
l ~,, I ( h.1d~s.: Procn7) me 
pcDNA4™frO/ 
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Figure 1: The T-Rex is tetracycline-regulated expression system composed of a 
regulatory plasmid which encodes the Tet-repressor and inducible expression vector used 
to express the gene of interest. Doxycycline is used to induce the expression. 
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4.11 Transfection of COS-7 Cells Containing the Regulatory Vector 
COS-7 cells containing the regulatory vector were grown in DMEM media 
containing Blasticidin (5 µg/ml). When the cells were 90-95% confluent, media was 
changed to FBS- free media and transfection was done one hour later. We used the 
transfection agent Gen-jet (Signagen, Gaithersburg, MD) with the ratio of DNA (2.4 
µg/ml) to agent 1 :3 (W: V). DNA and Gen-jet were placed in separate tubes containing 
FBS- free media and then mixed and incubated for 15 minutes. Then, transfection was 
done by adding the mixed media to the cells. During transfection, cells should be in 50% 
more media than during culture. 
4.12 Induction of the Cells Using Doxycycline 
Cells were induced to express and secrete lysyl oxidase proenzyme usmg 
doxycycline (Sigma, St. Louis, MO). The media of COS-7 cells was changed 24 h after 
transfection with media containing tetracycline (lµg/ml). Expression and secretion of 
lysyl oxidase proenzyme was analyzed by Western blots. 
4.13 Use of BMP-1 Inhibitor 
BMP-1 inhibitor (FG-2575) can be used, at a concentration of 5.15 µg/ml, to 
inhibit the processing of the secreted lysyl oxidase proenzyme by doxycycline- induced 
cells. The inhibitor is added at the time of induction (5.15 µg/ml). Equal volume of 
vehicle is added to the control cells. 
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4.14 Purification ofLysyl Oxidase Proenzyme form the media of COS-7 Cells 
COS-7 cells were transfected as mentioned previously. After 24 hours the cells 
were induced with tetracycline (1 µg/ml). Cell culture media were collected 48 hours 
after induction. The medium was vacuum-filtered using 0.45 µm CA (Cellulose Acetate) 
low protein binding membrane (Coming, Glendale, AZ). The vacuum was stopped and 
30 ml 16 mM potassium phosphate, 6 M urea buffer (pH 7 .8) buffer was used to elute 
lysyl proenzyme. One hour later, vacuum was applied again and the elution was analyzed 
by Western blotting and gel staining. 
4.15 The use of 293 EBNA to express and secret the human lysyl oxidase proenzyme 
preceded by His tag 
293 EBNA cells were transfected with the human lysyl oxidase proenzyme DNA 
sequence preceded by His tag. Cells were grown in DMEM containing 10% FBS (Sigma-
Aldrich, St. Louis, MO), 4 mM L-glutamine (Invitrogen, Carlsbad, CA). The media also 
contained 100 U/ml pen/strep (5ml), 300-µg/ml G418 geneticin (Sigma-Aldrich, St. 
Louis, MO) for EBNA selection, and 0.5-µg/ml puromycin (Sigma-Aldrich, St. Louis, 
MO) for pCEP pu selection. When cells were 95% confluent, media was changed to 
DMEM/F12 with Glutamax (Invitrogen, Carlsbad, CA). The media was collected after 
72h and was centrifuged of get rid of cell debris at 5000 rpm for 5 minutes. 30 µl of 
protease inhibitor cocktail (P8340 Sigma-Aldrich, St. Louis, MO) was added and then 
lysyl oxidase proenzyme was then extracted from the media using nickel column. The 
purification procedure was done the way as LOX-PP purification (Vora, Guo et al. 2010). 
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4.16 The use of enterokinase to remove histidine tag from Iysyl oxidase proenzyme 
During the purification procedure, 4 units of enterokinase (Invitrogen, Carlsbad, 
CA) was pumped in the column before the elution of lysyl oxidase proenzyme and the 
reaction was allowed to precede overnight at room temperature. The column was first 
washed with 15ml of 50mM Tris buffer pH 7.8 and a sample was taken. Then the column 
was washed with 15 ml of 50mM Tris, 6M urea buffer pH 7 .8 and a sample was taken. 
The column was then washed with 15ml 11 mM potassium phosphate, 8 M urea buffer 
pH 4.3 and a sample was taken. Samples were analyzed by western blotting. 
4.17 Processing of Lysyl Oxidase Proenzyme by BMP-1 
A pure sample of lysyl oxidase proenzyme was dialyzed against 1 liter of 50 mM 
Tris, 150 mM NaCl, 5 mM CaCh,pH 7.5 buffer for 6 hours with buffer changed after 1, 3 
and 5 hours. After that, 7 µg of lysyl oxidase proenzyme was incubated with 30 ng of 
commercially available BMP-1 (R&D systems, Minneapolis, MN) enzyme for 4 hours at 
3 7 ° C at a final volume of 200 µ1. In order to inhibit nonspecific proteinases we added 40 
µg/ml soybean trypsin inhibitor, 10 µg/ml leupeptin, and 0.4 mM 
phenylmethylsulfonylflouride (Uzel, Scott et al. 2001). A sample was aliquoted and 
mixed with an equal volume of SDS-PAGE sample buffer and boiled for 5 minutes and 
then subjected to 10% PAGE and western blotting to analyze the efficiency of the 
processing. The remaining sample was used in a flourometric assay to detect lysyl 
oxidase enzyme activity. 
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4.18 Western Blot Analysis 
Both forms of lysyl oxidase, the proenzyme and the mature form were separated 
m samples using 10% SDS-PAGE gel electrophoresis. Separated proteins were 
transferred overnight to PVDF membranes. The membranes were then blocked with milk 
for one hour then incubated overnight with affinity purified primary rabbit antibodies. 
Two types of antibodies were used; an affinity purified antibody that binds the mature 
form of lysyl oxidase (1 µg/ml), which also binds to the proenzyme form, and an affinity 
purified antibody against lysyl oxidase propeptide (0.4 µg/ml), which will also binds the 
proenzyme form. The next day, the membranes were washed four times, ten minutes each 
with TBST (20 mM Tris, 150 mM NaCl and 5 % Tween-20) to break nonspecific protein 
antibody interactions. The membranes were incubated with HRP goat anti-rabbit 
antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) for one hour. After that, the 
membranes were incubated for one minute with western blotting detection reagent (GE 
Healthcare) for one minute. Then the membranes were exposed using X-ray films. 
The mature form of lysyl oxidase is detected at 32 kDa; the proenzyme form 
usually runs at 50 kDa and the propeptide runs at 18 kDa. Two types of molecular weight 
markers were used; broad range pertained SDS-page standards (Bio-Rad, Hercules, CA) 
and kaleidoscope pre-stained standards (Bio-Rad, Hercules, CA). 
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4.19 Detection of Active Lysyl Oxidase by Fluorometric Assay 
We used a previously developed flourometric assay method to measure lysyl 
oxidase activity (Palamakumbura and Trackman 2002). Lysyl oxidase oxidatively 
deaminates alkyl monoamines and diamines according to the following equation 
(Trackman and Kagan 1979): 
RCH2NH2 + 02 + H20 _. RCHO + NH3 + H202 
The method depends on coupling this reaction with horseradish peroxidase-
catalyzed oxidation of N-Acetyl-3,7-dihydroxyphenoxazine (Amplex red). In the 
presence of horseradish peroxidase, hydrogen peroxide oxidizes amplex red to give 
fluorescent product with an excitation maximum at 563 nm and an emission maximum at 
587 nm. This assay is sensitive to 50 ng of pure lysyl oxidase. In this assay, 0.135 nmoles 
of hydrogen peroxide is produced by 0.29 µg of purified bovine aorta lysyl oxidase 
(Palamakumbura and Trackman 2002). 
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5. Results 
µCT analysis of selected areas of trabecular bone from the right femur and LS 
vertebrae from LOX+/- LOXLJ-1- and LOXLJ-1- mice show significant deterioration of 
trabecular bone geometry as explained by significant decreases in parameters such as 
BV /fV, connectivity density and trabecular number and significant increases in 
trabecular spacing. These changes were more significant in female than in male mice, 
which may provide some insight into gender hormones influence on the expression or 
activity of lysyl oxidases. The analysis of the cortical area of these bones show 
significant increase in TV and pMOI in the mutant mice, especially in the femur 
diaphysis. Histological analysis of the femur metaphysis and growth plates of the mutant 
mice show significant increases in osteoclasts numbers in the metaphysis and significant 
decrease in flat column forming cells in the growth plates. A more detailed explanation 
and discussion of the results follow. Femoral bone length measurements are shown in 
Table I. 
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Table I 
Genotype Mean (mm)+/- SD N 
Wild Type Male 16 +/- 0.8 8 
Wild Type Female 15.6 +/- 0.48 8 
LOXLJ-1- Male 15.4 +/- 0.7 8 
LOXLJ-1- Female 15.6 +/- 0.4 8 
LOX+/-, LOXLJ-1- Male 16.6 +/- 0.27 8 
LOX+/-, LOXLJ-1- Female 16 +/- 0.5 8 
Average femoral bone length of both male and female wild type, LOXLI-1-, and LOX+/-, 
LOXLJ-1- mice. No significant differences were found. 
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FEMALE 
Wild Type LOX+l-,LOXL 1-/-
MALE 
Wild Type LOX+l-,LOXL1-I-
LOXL1-I-
LOXL1-/-
Figure 2. Three-dimensional images for femur distal metaphysis representing wild type, 
LOXLJ-1- and LOX+/-, LOXLJ-1- mice. The 3-dimensional reconstructions show spaces 
and porosity within the trabeculae of both mutant mice compared to wild type controls. 
Analysis of the different parameters is presented in Figures 3A to 3H. 
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Figure 3. Three-dimensional images for L5 trabeculae representing wild type, LOXLJ-/-
and LOX+/-, LOXLJ-1- mice. As in the distal femur metaphysis, L5 vertebrae of the 
mutant mice show spacing and porosity. 
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5.1 Deterioration of Trabecular Bone of Femur Distal Metaphysis is Caused Mainly 
By LOX and LOXLl Deficiency 
LOXLJ-1- female mice show significant decrease in BV/TV (p<0.0001) (Figure 
4A), BV (p<0.0001) (Figure 4B), and Tb.Th. (p=0.0019) (Figure 4G) compared to both 
wild type and LOX+/-, LOXLJ-1-. Both male and female LOX+/-, LOXLJ-1- show 
significant increases in TV (p<0.0001) (Figure 4B). LOX+/-, LOXLJ-1- female mice 
show significant decrease in Conn.D. (p<0.0001) (Figure 4D) and Tb.N. (p<0.0001) 
(Figure 4E). They also show significant increase in Tb.Sp (p<0.0001) (Figure 4F). Tb.N. 
was significantly decreased in LOX+/-, LOXLJ-1- male mice (p<0.0001) (Figure 4E). 
Bone mineral density is significantly decreased (p=0.01) in LOXLJ-1- female mice 
(Figure 4H). Table II shows the percentage of change in the different parameters in 
LOXLJ-1- and LOX+/-, LOXLJ-1- mice relative to wild type mice. These percentages 
show more effect of the deficiency of LOXLJ alone on trabecular bone properties in 
females compared to wild type control females. The decrease in BV/TV is 75.3 % in 
LOXL-1- females compared to LOX+/-, LOXLJ-1- females (27.6%). Conn.Dis decreased 
by 82.1 % in LOXL-1- females compared to 34.7% in LOX+/-, LOXLJ-1- females. These 
results raise the question of the possibility of some compensation of other lysyl oxidases 
in the case of LOX+/- genotype. The fact that female mutant mice are more affected by 
LOX and LOXLJ gene ablation also raise the question of the possibility of gender 
regulation of the activity of these enzymes. 
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Figure. 4. Mean values+/- SD of different trabecular bone parameters from femur distal 
metaphysis from wild type, LOXLJ-1- and LOX+/-, LOXLJ-1- male and female mice. One 
asterisk (*) indicates significant difference from wild type and two asterisks (* *) 
indicates significance between the two mutant genotypes. Significant differences were 
found in LOXLJ-1- and LOX+/-, LOXLJ-1- female mice in parameters such as BV/TV , 
TV, Conn.D., Tb.N., and Tb.Th. The mutant male mice LOX+/- LOXLJ-1- show 
significant differences from WT mice in parameters such as Conn.D. and Tb.N. 
39 
Table II 
Genotype LOXLJ-1- LOX+/-, LOXLJ-1- LOX+/-, 
Females LOXLJ-1- Males LOXLJ-1-
Bone Females Males 
parameters 
BV/fV -75.3% (S) -27.6% (NS) 2.1 % (NS) -9.8% (NS) 
Conn.D -82.1 % (S) -34.7 % (S) -17.9% (NS) -26.8 % (NS) 
Tb.N -30% (S) -20 % (S) -15.4% (NS) -15.5 % (S) 
Tb.Th -22.3% (S) -1.8% (NS) 7.5 % (NS) 5.7% (NS) 
Tb.Sp 47.3 % (S) 31.42 % (S) 21.4 % (NS) 20.8 % (NS) 
Percentage of change in trabecular bone parameters in femur metaphysis of male and 
female LOXLJ-1- and LOX+/-, LOXLJ-1- mice. 
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5.2 Cortical Bone of Femur Diaphysis 
LOX+/-, LOXLJ-1- males and both female LOX+/-, LOXLJ-1- and LOXLl-/- mice 
show significant increases in TV (p<0.0001), pMOI (p<0.0001) and area (p<0.0001) 
(Figure 5 A,B, and C). These results suggest that femurs are getting larger in size and 
surface area and more resistant to torsion. The results also suggest that mice with more 
deterioration in trabecular bone may compensate by increasing quality of the cortical 
bone in the diaphysis. Both LOX+/-, LOXLJ-1- and LOXLl-/- (both genders) show non-
significant increase in cortical bone thickness (Figure 5 D). 
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Figure. 5. Mean values +/- SD of different cortical bone parameters from femur mid-
diaphysis region from wild type, LOX+/-, LOXLJ-1- and LOXLJ- 1- male and female 
mice. One asterisk (*) indicates a significant difference from wild type mice . The cortical 
parameters TV, pMOI, and area were significantly increased in the femurs of LOX/,1-/-
and LOX+/- , LOXLJ- 1- mutant female mice compared to WT controls. 
LOX+/-, LOXL l -/- mutant male mice show significant increase in TV, pMOI, and area 
in the femur cortex. 
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5.3 Trabecular Bone of LS Vertebrae Show combined Effects of Both Enzyme 
Deficiencies 
Next, we wished to investigate weather the trabecular bone in the vertebrae have 
similar abnormalities. The analysis shows that deterioration in trabecular bones in the 
vertebrae was more obvious in female mutant mice. Both LOX+/-, LOXLJ-1- and 
LOXLJ-1- female mutant mice show significant decreases in BV/TV (p=0.0003), 
Conn.D. (p=0.002) and Tb.N (p=0.0002) (Figure 6 A, B, and C). They show significant 
increases in TV and Tb.Sp (Figure 6 D and E). The differences in males were not 
significant (Figure 6). Table III shows the percentage of change in these parameters in 
LOX+/-, LOXLJ-1- and LOXLJ-1- mice relative to wild type mice. These percentages 
show a different pattern of bone parameters in the vertebrae than in the femurs. The loss 
in BV/TV is 64.1 % inLOXL-1- females and 49 % in LOX+/-, LOXLJ-1- females. Conn.D 
in decreased by 64.5 % in LOXL-1- females and 70.5 % in LOX+/-, LOXLJ-1- females. 
Tb.Sp is increased by 29.6% in LOXL-1- females and by 46.2 % in LOX+/-, LOXLJ-1-
females. The results show combined effect of both enzyme deficiencies in the vertebrae. 
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Figure. 6. Mean values+/- SD of different trabecular bone parameters from L5 vertebrae 
representing wild type, LOX+/-, LOXLJ -/- and LOXLJ -/- mutant male and female mice. 
One asterisk (*) indicates significant difference from wild type mice and two asterisks 
(**) indicates significance between the two mutant genotypes. LOXLJ-1- and LOX+/-, 
LOXLJ-1- female mice show significant decrease in different parameter in their L5 
vertebrae trabecular bone. Those parameters include BV/TV, Conn.D., and Tb.N. Tb.Sp. 
and TV were significantly increased. The mutant male mice did not show any significant 
differences. 
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Table III 
Genotype LOXLJ-1- LOX+/-, LOXLJ-1- LOX+/-, 
LOXLJ-1- LOXLJ-1-
Bone Females Females Males Males 
parameters 
BV!fV -64.1 % (S) -49 % (S) -24.2 % (NS) -12.1 %(NS) 
Conn.D -64.5 % (S) -70.5 % (S) -24.2 % (NS) -12.1 % (NS) 
Tb.N -21.3 % (S) -32.1 % (S) -8.4 % (NS) -4.2 % (NS) 
Tb.Th -22.3% (NS) -1.8% (NS) 7.5 % (NS) 5.7%(NS) 
Tb.Sp 29.6 % (S) 46.2 % (S) 11.2 % (NS) 5.6 % (NS) 
Percentage of change in trabecular bone parameters in L5 vertebrae of both male and 
female LOXLJ-1- and LOX+/-, LOXLJ-1- mice. 
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5.4 Cortical Shell of LS Vertebrae 
LOXLJ-1- females show significant decrease in BV (p=0.0023) and BV/TV (p =0.0008). 
Cortical thickness is non-significantly increased in both genders of LOXLJ-1- mice 
(Figure 7). 
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Figure 7. Mean values +/- SD of different cortical bone parameters from L5 cortical shell 
from wild type, LOX +/-, LOXLJ -/- and LOXLI-1- male and female mice. One asterisk (*) 
indicates significant difference from wild type and two asterisks (* *) indicates 
significance from LOXLJ-1- mice. BV/TV is significantly decreased in the cortical shell 
of L5 vertebrae in LOX +/-, LOXLJ-1- male mutant mice and LOXLJ-1- female mutant 
mice compared to their WT controls. 
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5.5 Histological Analysis of Femur Trabecular Bone and Growth Plates 
The analysis of osteoclast quantification around trabecular bone in femur 
metaphysis of the mutant mice show significant increase (p< 0.0001) in LOXLJ-1- and 
LOX+/-, LOXLJ-1- female mice when compared to wild type mice. LOX+/- , LOXLJ-1-
male mice show a significant increase (p<0.0001) when compared to LOXLJ-1- male 
mice (Figure 9). Analysis of the growth plates show significant decrease in the number of 
column forming cells in both LOXLJ-1- and LOX+/-, LOXLJ-1- mice when compared to 
wild type females (Figure 9). Parameters such as average growth plate height and 
chondrocytes density did not show significant differences ( data not shown). 
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Figure. 8. H&E staining of sagittal sections of femur distal growth plates representing 
wild type, LOXLJ-1- and LOX+/-, LOXLJ-1-mice. The sections show disorganization in 
the column forming chondrocytes in the growth plates of both mutant mice LOXLJ-1- and 
LOX+/-, LOXLJ-1-. Both males and female mice show this disorganization. 
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Figure. 9. Mean values +/- SD representing data obtained from the analysis of 
histological sections of femurs representing wild type, LOXLJ-1- and LOX+/-, LOXLJ-1-
mice. One asterisk (*) indicates significant difference from wild type and two asterisks 
(**) indicates significance from LOXLJ-1- mice. Osteoclasts count was significantly 
increased around femur bone trabeculae of LOX+/-, LOXLJ-1- male mice and both 
LOXLJ-1- and LOX+/-, LOXLJ-1- female mice. The average number of column-forming 
chondrocytes in the growth plates of LOXLJ-1- and LOX+/-, LOXLJ-1- female mice was 
significantly decreased. 
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5.6 Cross Link Analysis 
In an attempt to investigate the effect of LOX and LOXL 1 enzyme deficiency on 
the formation of collagen cross-links, we collected the tibia and fibula from each animal 
and sent the samples to the University of North Carolina, Chapel Hill, North Carolina, for 
cross-link analysis. Analysis of the reducible and non-reducible lysyl oxidase catalyzed 
cross links show that the total number of aldehydes is significantly decreased in the bones 
of the compound knockout mice, P=0.04 by two-way ANOV A (Table IV). It is not 
surprising to see such a decrease since these aldehydes are the first product of lysyl 
oxidases-catalyzed reactions. In general, the results show decrease in immature cross-
links in the bones of male and female LOX+/- LOXL-1- mice. This decrease is not 
statistically significant. The mature cross-link pyridinoline is decreased only in the bones 
of LOX+/-LOXL-1- mice. The decrease is also not statistically significant. 
On the other hand, comparison of the different cross-links in LOX+/+ LOXLJ-1- mice did 
not show any significant differences in the bones analyzed (Table V). These results 
elucidate the important role of lysyl oxidase on cross-link formation in mice bones. 
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Table IV 
Genotype & DHNL/lM DHLNL/lM HLNL/lM Pyr/(DHLNL + 
gender coll coll coll Pyr/lM coll Total aid DHLNL/HLNL HLNL) 
(mean +/- (mean+/- (mean+ /- (mean +/- (mean+/- (mean +/- (mean+/-
SD) SD) SD) SD) SD) SD) SD) 
Wild type 0.2048 +/- l.545 +/- 0.247 +/- 0.169 +/- 2.336 +/- 7.314 +/- 0.0986 +/-
Female 0.163 0.448 0.105 0.117 0.501 3.203 0.053 
LOX +/- 0.0854 +/- 1.149 +/- 0.1554 +/- 0.1074 +/- 1.602 +/- 7.562 +/- 0.083 +/-
LOXLJ -1- 0.027 0.318 0.042 0.046 0.453 1.838 0.017 
Female 
Wild type 0.115 +/- 1.351 +/- 0.236 +/- 0.1018 +/- 1.904 +/- 5.884 +/- 0.071 +/-
Male 0.038 0.174 0.058 0.024 0.249 0.901 0.019 
LOX +/- 0. 1048+/- 1.27 +/- 0.24 +/- 0.1354 +/- 1.884 +/- 5.566 +/- 0.097 +/-
LOXLJ- 1- 0.0255 0.1 0.067 0.051 0.105 1.3 0.037 
Male 
Mean values +/- SD for the different cross-links from the bones of LOX+/- LOXLJ-1-
mice and wild type mice. 
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Table V 
Genotype & DHNL/lM DHLNL/lM HLNL/lM Pyr/(DHLNL+ 
gender coll coll coll Pyr/IM coll Total aid DHLNL/HLNL HLNL) 
(mean +/- (mean+/- (mean+/- (mean +/- (mean+/- (mean+/- (mean+/-
SD) SD) SD) SD) SD) SD) SD) 
Wild type 0.12 +/- 0.79 +/- 0.16 +/- 0.31 +/- 1.68 +/- 5.1 +/- 0.33 +/-
Female 0.06 0.11 0.04 0.11 0.23 1.57 0.13 
LOXLJ-1- 0.12 +/- 1.1 +/- 0.22 +/- 0.19 +/- 1.83 +/- 4.98 +/- 0.14 +/-
Female 0.05 0.25 0.04 0.09 0.42 0.76 0.07 
Wild type 0.12 +/- 0.91 +/- 0.19 +/- 0.15 +/- 1.52 +/- 4.69 +/- 0.14 +/-
Male O.o3 0.25 O.o3 0.05 0.31 0.83 0.05 
LOXLJ-1- 0.12+/- 0.98 +/- 0.22 +/- 0.19 +/- 1.61 +/- 4.3 +/- 0.17 +/-
Male 0.02 0.19 0.06 0.05 0.27 1.44 0.04 
Mean values +/- SD for the different cross-links from the bones of LOXLJ-1- and wild 
type mice. 
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5. 7 Use of COS- 7 Cells to Express Lysyl Oxidase Proenzyme 
From our previous work, we tried to induce human 293 cells to produce large 
amounts of lysyl oxidase proenzyme. The cells secreted small amounts of the proenzyme 
but a large portion was entrapped within the cell. The inability to purify enough amounts 
of lysyl oxidase from the cell layer of 293 cells has led us to use different types of cells. 
CHO cells gave negative results. Stable COS-7 cells that integrated the regulatory 
plasmid were grown to become 90-95% confluent. They were then transfected with the 
expression vector. Expression and secretion of lysyl oxidase proenzyme was analyzed by 
SDS-P AGE over different time points. The results show that they do express and secrete 
lysyl oxidase proenzyme into the culture media. The expression and secretion peaks at 48 
hours. 
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Figure 10: Western blot analysis of media samples using lysyl oxidase antibody was used 
to analyze the expression and secretion of lysyl oxidase proenzyme form COS-7 cells. 
Expression and secretion reach peak at 48 hours. 
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5.8 Purification of Lysyl Oxidase Proenzyme from the Culture Media of Induced 
COS-7 Cells 
After transfection with the expression vector, COS-7 cells were induced with 
doxycycline (lµg/ml) and the culture media was collected after 48 hours from induction. 
Upon filtration the media in cellulose acetate membrane, the proenzyme present in the 
media bound to the membrane and was eluted using buffered 6 M urea. The urea elute 
was treated with hydroxyapatite and concentrated. Western blotting and gel staining show 
strong band for the proenzyme with some impurities. 
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Figure 11: Western blots and gel staining for the purification of lysyl oxidase from the 
culture media of COS-7 cells. A and B present western blots of urea elution before and 
after treatment by hydroxyapatite Bio-Gel (Bio-Rad, Hercules, CA), respectively. C and 
D represent gel staining of urea elution before and after hydroxyapatite treatment, 
respectively. Before using the gel, 5 gm of hydroxyapatite powder is hydrated with 30 ml 
of 0.2 M potassium phosphate buffer pH 7.8 for 10 minutes. The hydroxyapatite is 
allowed to settle and the buffer is replaced and the process is repeated until the pH is 
within 0.05 units of the starting buffer. The powder is then equilibrated with 0.016 M 
potassium phosphate pH 7 .8 until the pH of the used buffer is within 0.05 units from pH 
of the starting buffer. The equilibrated hydroxyapatite can be stored in the same buffer. 
Lysyl oxidase eluted with 6 M urea is mixed with the equilibrated powder and stirred for 
10 minutes at 4° C and allowed to settle for 30 minutes. The supernatant is clarified by 
centrifugation at 10,000g for 10 minutes and then concentrated. 
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5.9 Processing of Lysyl Oxidase Proenzyme by BMP-1 
Lysyl oxidase proenzyme purified from the culture media of COS-7 cells was 
incubated with BMP-1 for processing into the mature lysyl oxidase enzyme. Culture 
media of COS-7 cells transfected with PcDNA4 was used as control. Samples were taken 
at 0, 2, and 4h and analyzed by western blotting using lysyl oxidase antibody. The results 
show almost complete processing into the mature enzyme at 4h. 
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Figure 12: 7 µg of lysyl oxidase proenzyme was incubated with 30 ng of commercially 
available BMP-1 enzyme for 0,2 and 4 hours at 37° C. Equal volume of the control 
extract was incubated with the same amount of BMP-1 for the same time points. The 
processing reaction was analyzed by Western blotting using lysyl oxidase antibody. 
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5.10 Detection of Mature Lysyl Oxidase Activity using Flourometric Assay 
Samples from the processing reaction were used in the flourometric assay 
described in the materials and methods to detect the activity of mature lysyl oxidase 
enzyme produced from processing Pro-Lox by BMP-1. The first experiment showed that 
after 4 hours of incubation with BMP-1, there was activity corresponding to 0. 7 µg/ml of 
active lysyl oxidase. Unfortunately, we were unable to get positive activity from the 
fo11owing experiments. 
5.11 Lysyl Oxidase Proenzyme was secreted and then purified from the media of 293 
EBNA cells. 
The purification of lysyl oxidase proenzyme from the media of 293 EBNA ce11s 
using nickel column resulted pure extract of the proenzyme with the concentration of 0.1 
µg/µl. The elutions were analyzed by SDS-PAGE using LOX-PP antibody and gel 
staining. We tried to incubate Pro-LOX with BMP-1 in an attempt to process the mature 
enzyme but the processing reaction was unsuccessful. We thought that the reason for the 
inability to process the proenzyme is the presence of histidine tag. So we used 
enterokinase enzyme to remove the histidine tag. The different elutions were analyzed by 
SDS-PAGE and the use of LOX-PP and lysyl oxidase antibodies. The results show that 
washing the column initia11y with 50 mM tris buffer pH 7 .8 alone gave the largest amount 
of proenzyme in the sample. Our attempts to process the proenzyme by incubation with 
BMP-1 were unsuccessful. 
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Figure 13: 3 µg of lysyl oxidase purified from the media of 293 EBNA cells. Samples 
were analyzed using SDS-PAGE (Figure A) using LOX-PP antibody and gel staining 
(Figure B). Bands of lysyl oxidase proenzyme were detected at 50 kDa. 
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Figure 14: Samples from the different elutions from the column after enterokinase 
reaction were concentrated and analyzed by SDS-P AGE and using lysyl oxidase antibody 
(1) LOX-PP antibody (2). A represents concentrated sample from the elution using 15 ml 
of 50 mM tris buffer pH 7.8, B represents concentrated sample from elution using 15ml 
of 50 mM tris, 6M urea buffer pH 7.8, and C represents concentrated sample from the 
elution using 15 ml of 100 mM potassium phosphate, 8 M urea buffer pH 4.3. 
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6. Discussion 
The presented results suggest that lysyl oxidase and lysyl oxidase like one are 
important enzymes for bone development and maturation. Bones in 12-week old mice 
with LOX+/-, LOXLJ-1- and LOXL-1- genotypes are not well developed with spaces and 
defects within their trabeculae. These defects are of close similarity to the defects 
observed in some bone pathologies such as osteoporosis and diabetic bone disease. 
Different studies on animals were done to analyze bone characteristics when the animals 
experience such diseases. Ovarectomy-induced osteoporosis is done to resemble post-
menopausal osteoporosis. A study indicates that one month after ovarectomy, vertebral 
trabecular BV/TB declined (15 to 24%) in four different strains of mice which were 
BALB/cByJ, CAST/EiJ, DBA2/J and C57BL6J (Bouxsein, Myers et al. 2005). The 
activity or the levels of lysyl oxidases could be decreased during menopause due to 
estrogen deficiency. The presence of gender differences with females showing more 
significant bone defects due to LOX and LOXLl gene ablation in our results support this 
notion. Similar bone changes are also noticed in age-related bone osteoporosis. A study 
on mice from the strain C57BL/6J shows that with aging, female mice experience greater 
deterioration in BV/TV and more generalized trabecular bone defects than male mice of 
the same strain (Glatt, Canalis et al. 2007). 
The presence of such trabecular bone defects in femur metaphysis and vertebral 
body trabeculae indicates a generalized bone phenotype affecting both the appendicular 
as well as the axial skeleton. The defects are elucidated mainly by the decrease in relative 
bone volume (BV /TV) in the different areas. The variability in response with respect to 
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the different bone parameters obtained from µCT analysis is a reflection of the 
differences between femoral and vertebral bones. Vertebral bones have more 
trabeculation through the length of the vertebral body while long bones have 
trabeculation only at the ends in metaphysis and epiphysis. The more profound trabecular 
bone deterioration in the vertebrae is relevant because it is the main site for osteoporotic 
fractures in the spinal column. Vertebral fractures may cause loss of vertebral height and 
stability, risk of neurological injury and pain, which render osteoporotic fractures a major 
disabling problems {Tommasini, Morgan et al. 2005). 
Some variability's exist between long bones and vertebrae in the response to 
LOX+/-, LOXLJ-1- and LOXLJ-1- genotypes. While male mutant mice did not show 
significant differences, female mutant mice show significant differences in several 
parameters. LOXLJ-1- genotype caused more defects in trabecular bone architecture in 
femurs than LOX+/- LOXLJ-1- genotype. On the other hand, in mutant female mice, 
abnormalities in vertebral bone architecture were almost similar between LOX+/-, 
LOXLJ-1- and LOXLJ-1- genotypes. This indicates that females are more prone to 
trabecular bone loss due to deficiency of lysyl oxidase enzymes. LOXLJ-1- female mice 
show more trabecular bone loss in femurs than LOX+/-LOXLJ-1- female mice. This may 
explain some compensatory role of the lysyl oxidase family members. In the vertebrae, 
LOX+/-, LOXLJ-1- and LOXLJ-1- female mice show similar trabecular bone properties. 
This indicates a more significant role for LOXLJ in the vertebrae rather than LOX. This 
heterogeneity and gender differences in response to gene deletions could come from the 
differences in trabecular bone architecture in the body. A study on 165 subjects analyzing 
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trabecular bone architecture at six different locations reported that trabecular bone 
architecture was heterogeneous all over the skeleton and that significant sex differences 
between men and women subjects were observed (Eckstein, Matsuura et al. 2007). 
Cortical bone is used to build long bones, which are used as levers for movement 
and loading. Long bones achieve structural stiffness and lightness by forming marrow 
spaces. Resorption within the marrow cavity causes the cortex to move away from the 
central axis. Long bones grow in length by endochondral supposition on the endosteal 
surface and in width by deposition of bone on the periosteal surface(Seeman and Delmas 
2006). While the mutant mice were unable to develop normal trabecular bone, they were 
increasing the thickness of the outer cortical layer. The functional loading on one hand 
and the lack of internal support on the other hand may have led to this bone morphology. 
This compensation of increasing the cortical thickness to overcome the internal porosity 
was seen in the femurs of both mutants and in the vertebrae of LOXLJ-1- mice. Even 
though the trabecular bone defects were more advanced in the vertebral body, bone 
mineral density was maintained to compensate for trabecular defects. 
The decrease in trabecular number may be the result of remodeling activity in an 
attempt to create more efficient and organized trabecular bone morphology (Ruimerman, 
Hilbers et al. 2005). Only femurs of LOXLJ-1- female mice had significant decreases in 
trabecular thickness while trabecular thickness was not significantly changed in vertebrae 
or femurs of other knockouts. This could be a compensatory mechanism to overcome the 
low number. This feature is explained in age related changes in C57BL6/6J mice (Glatt, 
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Canalis et al. 2007) and was also observed by Halloran et al in the same strain of mice 
(Halloran, Ferguson et al. 2002). 
Histological analysis were performed to support data obtained from µCT analysis 
and to investigate whether the observed phenotype is due to less bone formation or 
increased bone resorption. Analyses of Osteoclasts shows significant increases in number 
on the surface of bone trabeculae in the femurs of LOX+/-, LOXL-1-and LOXLJ-1-female 
mice. These two groups also show significant bone deterioration from µCT analysis. This 
abnormal increase in bone resorption may be caused by lack of regulatory function of 
lysyl oxidase on osteoblast cell proliferation and maturation and in accordance with 
RANKL/OPG system. Another piece in the puzzle could be the lysyl oxidase propeptide. 
After secretion, lysyl oxidase proenzyme is processed by BMP-1 to release the 32-kDa 
mature enzyme and the 18-kDa propeptide. The functions and fate of the propeptide are 
unknown and are under investigations. A study by Guo et al, 2007 suggests that after 
extracellular release, the lysyl oxidase propeptide is taken up by osteoblastic cells. Within 
differentiating osteoblasts, the propeptide interacts and binds with microtubules (Guo, 
Pischon et al. 2007). Microtubules are cytoskeletal proteins that have functions such as 
determination of cell division, the shape of the cell and its polarity, cell movement and 
signal transduction (Downing 2000). This association between the propeptide and 
microtubules suggest important functions of the lysyl oxidase propeptide in regulating 
proliferation and differentiation of osteoblasts (Guo, Pischon et al. 2007). These mutant 
mice may have lost an important regulator of osteoblasts, which in tum regulates 
osteoclasts. Investigation of whether lysyl oxidase or its propeptide regulates the 
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proliferation of preosteoblasts or their differentiation to osteoblasts may elucidate the 
complex effects of this gene deletion on the regulation of the biology of bone cells. 
Mutant mice in this study tend to show more bone loss in trabecular area than in cortical 
bone, associated with increasing osteoclast ratio around trabeculae. One explanation was 
that there is some sort of compensation by increasing cortical bone thickness. The other 
reason could be that only the inner surface of the cortical bone is exposed to osteoclastic 
bone resorption, while osteoclasts surround the trabeculae within the marrow space 
exposing them to more osteoclastic bone resorption. Assessment of the number of 
osteoblasts could explain the anabolic role in these mutant mice. 
LOX enzyme deficiency affected the organization of chondrocytes within the 
distal femur growth plates. The decrease in the average number of column forming cells 
is observed along with the disorganized cell zones. A study on chondrocytes in two 
dimensional cultures report that inhibition of lysyl oxidase activity by BAPN prevented 
or delayed chondrocyte de-differentiation; a process that involves a change in 
morphology and a change of chondrocytes production of genes specific to chondrocytes 
to those specific to fibroblasts. The study was done by culturing proliferative and 
hypertrophic chick embryo stema chondrocytes in the presence and absence of BAPN. 
Lysyl oxidase production and activity was assessed by a specific enzyme assay and 
specific antibodies. Cell morphology and biochemical markers were used to assess 
chondrocyte phenotype (Farjanel, Seve et al. 2005). Our results show that the absence or 
deficiency of Lysyl oxidase and to a lesser extent lysyl oxidase like one ( especially in 
females) affect the organization and the number of column forming chondrocytes, which 
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may affect their proliferation and differentiation within the growth plates. These 
abnormalities may affect the normal deposition of cartilage template and hence lead to 
abnormal endochondral bone formation. 
The presented abnormalities in trabecular bone show some similarities to age-
related changes in bone (Khosla and Riggs 2005) and postmenopausal osteoporosis 
(Raisz 2005). Estrogen is a key element in the regulation of bone remodeling and 
prevention of bone loss. It suppresses RANKL production by osteoblastic, B cells and T 
cells and also increases OPG production (Hofbauer, K.hosla et al. 1999). Estrogen also 
regulates the production of different cytokines in osteoblasts or bone marrow cells, thus 
modulating osteoclastic activity (Hofbauer, Khosla et al. 1999). Following estrogen 
deficiency, different bone-resorbing cytokine are up-regulated. Those cytokines include 
IL-1, IL-6, TNF-a, and M-CSF (Pacifici, Brown et al. 1991). The down-regulationn of 
lysyl oxidase expression and activity in osteoblasts by TNF-a (Pischon, Darbois et al. 
2004) provides insights into the possibility of the down regulation of lysyl oxidase 
during postmenopausal osteoporosis, in which TNF-a is up regulated due to 
estrogen deficiency (Teitelbaum 2004). 
We are able to purify the lysyl oxidase proenzyme from the media of COS-7 cells 
and process it. Unfortunately, we could not get enough amounts of the protein and once 
processed, we were unable to get activity. When we used 293-EBNA cells, we were able 
to produce larger amounts of the proenzyme and purify it but we were unable to process 
it. One explanation for that could that the proenzyme made contains histidine tag within 
the propeptice sequence. Information obtained later indicated that the protein produced 
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by these cells that were provided by a colleague in Scotland was mutated could provide 
no LOX enzyme. 
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7. Conclusion 
LOX and LOXL 1 are important enzymes for normal bone growth and maturation. 
Their deficiency results in abnormal bone architecture with spacing and porosity within 
the trabeculae in appendicular as well axial bones. These abnormalities could be due to 
increased bone resorption as observed by increased osteoclast count or decrease in bone 
formation as observed from abnormalities in the growth plates and the number of 
enzyme-catalyzed cross-links. 
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